Clinical trial

Nasal Intermittent Positive Pressure Ventilation in Premature Infants (NIPPV)

NCT00433212 · McMaster University, Other · Completed

Key facts

NCT number NCT00433212
Title Nasal Intermittent Positive Pressure Ventilation in Premature Infants (NIPPV)
Official title Efficacy and Safety of NIPPV to Increase Survival Without Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants
Acronym NIPPV
Lead sponsor McMaster University, Other
Collaborators Canadian Institutes of Health Research (CIHR)
Status Completed
Phase Phase 3
Study type Interventional
Conditions Respiratory Insufficiency of Prematurity
Intervention type Device
Interventions nCPAP, NIPPV
Enrollment 1,011
Start date Apr 1, 2007
Primary completion Aug 1, 2011
Completion Dec 1, 2011
First posted Feb 9, 2007
Last update posted Dec 5, 2014
Countries Austria, Belgium, Canada, Ireland, Netherlands, Qatar, Singapore, Sweden, United Kingdom, United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies